Laura Campogiani
About
Laura Campogiani is a scholar working on Infectious Diseases, Epidemiology and Public Health, Environmental and Occupational Health.
According to data from OpenAlex, Laura Campogiani has authored 32 papers receiving a total of 222 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Infectious Diseases, 13 papers in Epidemiology and 5 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Laura Campogiani's work include SARS-CoV-2 and COVID-19 Research (6 papers), Pneumonia and Respiratory Infections (5 papers) and Antibiotic Use and Resistance (5 papers). Laura Campogiani is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (6 papers), Pneumonia and Respiratory Infections (5 papers) and Antibiotic Use and Resistance (5 papers). Laura Campogiani collaborates with scholars based in Italy, Spain and France. Laura Campogiani's co-authors include Jordi Rello, Loredana Sarmati, Sofía Tejada, Massimo Andreoni, Vincenzo Malagnino, Elisabetta Teti, Marco Iannetta, João Ferreira‐Coimbra, Daniela Fraboni and Francesco Buccisano and has published in prestigious journals such as Scientific Reports, Frontiers in Immunology and Frontiers in Microbiology.
In The Last Decade
Laura Campogiani
29 papers receiving 219 citations
Peers
Laura Campogiani
Cristina de la Calle Spain
Aydın Deveci Türkiye
Derya Seyman Türkiye
Yasemin Akkoyunlu Türkiye
Zümrüt Şahbudak Bal Türkiye
Teppei Shimasaki Japan
Maryann Shango United States
Hacer Aktürk Türkiye
Mickaël Aoun Belgium
Jeong Eun Lee South Korea
Citations per year, relative to Laura Campogiani Laura Campogiani (= 1×)
peers
Cristina de la Calle
Countries citing papers authored by Laura Campogiani
Since
Specialization
Citations
This map shows the geographic impact of Laura Campogiani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Campogiani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Campogiani more than expected).
Fields of papers citing papers by Laura Campogiani
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Laura Campogiani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Campogiani. The network helps show where Laura Campogiani may publish in the future.
Co-authorship network of co-authors of Laura Campogiani
This figure shows the co-authorship network connecting the top 25 collaborators of Laura Campogiani. A scholar is included among the top collaborators of Laura Campogiani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Campogiani. Laura Campogiani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Lorenzo, Andrea Di, Drieda Zaçe, Domenico Benvenuto, et al.. (2024). Histoplasmosis in patients living with HIV in Europe: review of literature. Frontiers in Microbiology. 15. 1418530–1418530.
2.
Oliva, Alessandra, Laura Campogiani, A Lodi, et al.. (2023). Clinical Characteristics and Outcome of Ceftazidime/Avibactam-Resistant Klebsiella pneumoniae Carbapenemase–Producing Klebsiella pneumoniae Infections: A Retrospective, Observational, 2-Center Clinical Study. Open Forum Infectious Diseases. 10(7). ofad327–ofad327.
3.
Campogiani, Laura, Luigi Coppola, Mirko Compagno, et al.. (2023). Real-life Data on Cefiderocol Efficacy and Safety to Treat Multidrug-Resistant Acinetobacter baumannii Infections. Open Forum Infectious Diseases. 10(12). ofad627–ofad627.
4.
Campogiani, Laura, A Lodi, Carla Fontana, et al.. (2023). Resistance to Ceftazidime/Avibactam in Klebsiella pneumoniae KPC-Producing Isolates: A Real-Life Observational Study. Antibiotics. 12(5). 820–820.
5.
Lorenzo, Andrea Di, Laura Campogiani, Marco Iannetta, et al.. (2023). The Impact of Viral and Bacterial Co-Infections and Home Antibiotic Treatment in SARS-CoV-2 Hospitalized Patients at the Policlinico Tor Vergata Hospital, Rome, Italy. Antibiotics. 12(9). 1348–1348.
6.
Rossi, Benedetta, Domenico Benvenuto, Laura Campogiani, et al.. (2023). Human Arboviral Infections in Italy: Past, Current, and Future Challenges. Viruses. 15(2). 368–368.
7.
Campogiani, Laura, Marco Iannetta, Andrea Di Lorenzo, et al.. (2023). Remdesivir Influence on SARS-CoV-2 RNA Viral Load Kinetics in Nasopharyngeal Swab Specimens of COVID-19 Hospitalized Patients: A Real-Life Experience. Microorganisms. 11(2). 312–312.
8.
Iannetta, Marco, Andrea Di Lorenzo, Laura Campogiani, et al.. (2022). Hepatitis B–Related Hepatic Flare During Immune Reconstitution Syndrome After Antiretroviral Treatment Initiation in an HBV Surface Antigen–Positive Patient With HIV: Viroimmunological and Histological Characterization. Open Forum Infectious Diseases. 9(9). ofac451–ofac451.
9.
Compagno, Mirko, Assunta Navarra, Laura Campogiani, et al.. (2022). Latent Tuberculosis Infection in Haematopoietic Stem Cell Transplant Recipients: A Retrospective Italian Cohort Study in Tor Vergata University Hospital, Rome. International Journal of Environmental Research and Public Health. 19(17). 10693–10693.
10.
Iannetta, Marco, Doriana Landi, Gaia Cola, et al.. (2022). B- and T-Cell Responses After SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Receiving Disease Modifying Therapies: Immunological Patterns and Clinical Implications. Frontiers in Immunology. 12. 796482–796482.
11.
Fontana, Carla, Marco Favaro, Laura Campogiani, et al.. (2021). Ceftazidime/Avibactam-Resistant Klebsiella pneumoniae subsp. pneumoniae Isolates in a Tertiary Italian Hospital: Identification of a New Mutation of the Carbapenemase Type 3 (KPC-3) Gene Conferring Ceftazidime/Avibactam Resistance. Microorganisms. 9(11). 2356–2356.
12.
Tejada, Sofía, Laura Campogiani, Candela Solé-Lleonart, et al.. (2021). Inhaled antibiotics for treatment of adults with non-cystic fibrosis bronchiectasis: A systematic review and meta-analysis. European Journal of Internal Medicine. 90. 77–88.
13.
Iannetta, Marco, Francesco Buccisano, Daniela Fraboni, et al.. (2021). Baseline T-lymphocyte subset absolute counts can predict both outcome and severity in SARS-CoV-2 infected patients: a single center study. Scientific Reports. 11(1). 12762–12762.
14.
Iannetta, Marco, Doriana Landi, Gaia Cola, et al.. (2021). T-cell responses to SARS-CoV-2 in multiple sclerosis patients treated with ocrelizumab healed from COVID-19 with absent or low anti-spike antibody titers. Multiple Sclerosis and Related Disorders. 55. 103157–103157.
15.
Malagnino, Vincenzo, Carlotta Cerva, Elisabetta Teti, et al.. (2021). Poor CD4/CD8 ratio recovery in HBcAb-positive HIV patients with worse immune status is associated with significantly higher CD8 cell numbers. Scientific Reports. 11(1). 3965–3965.
16.
Tejada, Sofía, Laura Campogiani, Candela Solé-Lleonart, & Jordi Rello. (2020). Alternative Regimens of Neuraminidase Inhibitors for Therapy of Hospitalized Adults with Influenza: A Systematic Review of Randomized Controlled Trials. Advances in Therapy. 37(6). 2646–2666.
17.
Tejada, Sofía, Laura Campogiani, João Ferreira‐Coimbra, Stijn Blot, & Jordi Rello. (2020). Levels of evidence supporting clinical practice guidelines on invasive aspergillosis. European Journal of Clinical Microbiology & Infectious Diseases. 39(5). 903–913.
18.
Campogiani, Laura, Mirko Compagno, Luigi Coppola, et al.. (2019). Tuberculosis-Related Hospitalizations in a Low-Incidence Country: A Retrospective Analysis in Two Italian Infectious Diseases Wards. International Journal of Environmental Research and Public Health. 17(1). 124–124.
19.
Rello, Jordi, Laura Campogiani, & Vandana Kalwaje Eshwara. (2019). Understanding resistance in enterococcal infections. Intensive Care Medicine. 46(2). 353–356.
20.
Campogiani, Laura, Carlotta Cerva, Gaetano Maffongelli, et al.. (2019). Remission of an HHV8-related extracavitary primary effusion lymphoma in an HIV-positive patient during antiretroviral treatment containing dolutegravir. AIDS Research and Therapy. 16(1). 15–15.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Cristina de la Calle Breakdown of academic impact, for papers by Aydın Deveci Breakdown of academic impact, for papers by Derya Seyman Breakdown of academic impact, for papers by Yasemin Akkoyunlu Breakdown of academic impact, for papers by Zümrüt Şahbudak Bal Breakdown of academic impact, for papers by Teppei Shimasaki Breakdown of academic impact, for papers by Maryann Shango Breakdown of academic impact, for papers by Hacer Aktürk Breakdown of academic impact, for papers by Mickaël Aoun Breakdown of academic impact, for papers by Jeong Eun Lee